A reliable, noninvasive method for the monitoring of patients with transiti
onal cell carcinoma (TCC) of the bladder is of great clinical benefit. Cyst
oscopy, the "gold standard" in the follow up of these patients is invasive,
expensive and causes discomfort. Recently, a new tool in the diagnosis of
de novo bladder cancer could be established based on microsatellite analysi
s of the urine DNA. To investigate the value of this approach in the follow
up of patients, we analyzed serial urine samples of 21 patients who were t
reated for TCC by 20 polymorphic microsatellite markers in a blinded fashio
n. Recurrent lesions could be detected in 10 of 11 cases, neoplastic cell p
opulations could be correctly predicted in 2 patients 4 and 6 months before
endoscopic evidence of a tumor. The test was negative in all patients with
no recurrent lesions. Microsatellite analysis is a novel and potentially p
owerful method in the detection of recurrent bladder tumors.